<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Transposable elements (TEs) are abundant in the human genome, and some are capable of generating new insertions through <z:chebi fb="40" ids="33697">RNA</z:chebi> intermediates </plain></SENT>
<SENT sid="1" pm="."><plain>In <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, the disruption of cellular mechanisms that normally suppress TE activity may facilitate mutagenic retrotranspositions </plain></SENT>
<SENT sid="2" pm="."><plain>We performed single-nucleotide resolution analysis of TE insertions in 43 high-coverage whole-genome sequencing data sets from five <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> types </plain></SENT>
<SENT sid="3" pm="."><plain>We identified 194 high-confidence somatic TE insertions, as well as thousands of polymorphic TE insertions in matched <z:mpath ids='MPATH_458'>normal</z:mpath> genomes </plain></SENT>
<SENT sid="4" pm="."><plain>Somatic insertions were present in <z:e sem="disease" ids="C0205853" disease_type="Neoplastic Process" abbrv="">epithelial tumors</z:e> but not in blood or <z:e sem="disease" ids="C0153633" disease_type="Neoplastic Process" abbrv="">brain cancers</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Somatic L1 insertions tend to occur in genes that are commonly mutated in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, disrupt the expression of the target genes, and are biased toward regions of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific DNA hypomethylation, highlighting their potential impact in <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
</text></document>